Thomas Uhde to Norepinephrine
This is a "connection" page, showing publications Thomas Uhde has written about Norepinephrine.
Connection Strength
0.508
-
The relationship between plasma MHPG and NE: employing regression models in estimating centrally derived MHPG and peripheral NE turnover rate in panic disorder. J Psychiatr Res. 1998 Jan-Feb; 32(1):11-7.
Score: 0.138
-
Heart rate and plasma norepinephrine responsivity to orthostatic challenge in anxiety disorders. Comparison of patients with panic disorder and social phobia and normal control subjects. Arch Gen Psychiatry. 1992 Apr; 49(4):311-7.
Score: 0.093
-
Noradrenergic challenges in the affective disorders. J Clin Psychopharmacol. 1981 Jul; 1(4):193-206.
Score: 0.044
-
Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls. Psychiatry Res. 1997 Jun 16; 71(1):27-39.
Score: 0.033
-
Anxiety and growth disturbance: is there a connection? A review of biological studies in social phobia. J Clin Psychiatry. 1994 Jun; 55 Suppl:17-27.
Score: 0.027
-
Growth hormone response to clonidine in the nervous pointer dog model of anxiety. Anxiety. 1994; 1(2):45-9.
Score: 0.026
-
Biogenic amines distribution in the brain of nervous and normal pointer dogs. A genetic animal model of anxiety. Neuropsychopharmacology. 1990 Aug; 3(4):297-303.
Score: 0.021
-
Indices of noradrenergic output in depression. Psychiatry Res. 1986 Sep; 19(1):59-73.
Score: 0.016
-
Effects of carbamazepine on noradrenergic mechanisms in affectively ill patients. Psychopharmacology (Berl). 1985; 87(1):59-63.
Score: 0.014
-
New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine. Biol Psychiatry. 1984 Feb; 19(2):131-56.
Score: 0.013
-
Extreme elevations in plasma norepinephrine associated with decreased alpha-adrenergic responsiveness in major depressive disorder: two case reports. J Clin Psychopharmacol. 1983 Feb; 3(1):39-41.
Score: 0.012
-
Abnormalities in the primary affective disorders compared to other tricyclic-responsive disorders. Psychopharmacol Bull. 1983; 19(3):435-6.
Score: 0.012
-
[Biochemical aspects of anxiety]. Sem Hop. 1982 Dec 02; 58(44):2573-9.
Score: 0.012
-
Evaluation of alpha-adrenergic responsiveness to clonidine challenge and noradrenergic metabolism in the affective disorders and their treatment. Psychopharmacol Bull. 1982 Oct; 18(4):118-9.
Score: 0.012
-
Biological peripheral correlates of anxiety. Encephale. 1982; 8(2):119-30.
Score: 0.011
-
The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry. 1986 Jul; 143(7):896-9.
Score: 0.004
-
Biological alterations in the primary affective disorders and other tricyclic-responsive disorders. Prog Neuropsychopharmacol Biol Psychiatry. 1985; 9(1):15-24.
Score: 0.004
-
Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects. Am J Psychiatry. 1984 Jun; 141(6):733-41.
Score: 0.003
-
The efficacy of carbamazepine in affective illness. Adv Biochem Psychopharmacol. 1984; 39:421-37.
Score: 0.003
-
Growth hormone response to clonidine in obsessive-compulsive patients. Br J Psychiatry. 1983 Feb; 142:184-7.
Score: 0.003
-
Clinical studies of monoamine receptors in the affective disorders and receptor changes with antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry. 1983; 7(2-3):249-61.
Score: 0.003
-
Possible subsensitization of alpha 2-adrenergic receptors by chronic monoamine oxidase inhibitor treatment in psychiatric patients. Psychiatry Res. 1982 Jun; 6(3):293-302.
Score: 0.003